Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
Title:
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
Author:
Mittendorf, E.A. Ardavanis, A. Symanowski, J. Murray, J.L. Shumway, N.M. Litton, J.K. Hale, D.F. Perez, S.A. Anastasopoulou, E.A. Pistamaltzian, N.F. Ponniah, S. Baxevanis, C.N. von Hofe, E. Papamichail, M. Peoples, G.E.